Taipei, Taiwan

Wei-Ying Kuo


Average Co-Inventor Count = 11.0

ph-index = 1


Company Filing History:


Years Active: 2019-2020

where 'Filed Patents' based on already Granted Patents

3 patents (USPTO):

Title: Wei-Ying Kuo: Innovator in Antibody Fragment Screening

Introduction

Wei-Ying Kuo is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of immunology through his innovative approaches to antibody fragment screening. With a total of 3 patents, Kuo's work focuses on developing methods that enhance the efficacy of immunoconjugates in targeting cancer cells.

Latest Patents

Kuo's latest patents include groundbreaking technologies such as high-throughput screening of functional antibody fragments, immunoconjugates comprising the same, and adaptor-drug conjugates for screening. The first patent discloses methods for high-throughput screening of functional antibody fragments for immunoconjugates that target protein antigens. This method combines a phage-displayed synthetic antibody library with high-throughput cytotoxicity screening to identify highly functional synthetic antibody fragments for delivering toxin payloads. The second patent details an immunoconjugate that includes an antibody, a functional motif, and a linker connecting the functional motif to the antibody. This immunoconjugate is designed to recognize tumor-associated antigens (TAAs) and serves as a targeting module for delivering functional motifs to tumor cells, thereby inhibiting tumor growth or aiding in the detection of tumor cell distribution.

Career Highlights

Wei-Ying Kuo is affiliated with Academia Sinica, a prestigious research institution in Taiwan. His work has significantly advanced the understanding and application of immunoconjugates in cancer treatment. Kuo's innovative methods have the potential to revolutionize how cancer therapies are developed and implemented.

Collaborations

Kuo has collaborated with notable colleagues such as An-Suei Yang and Hong-Sen Chen. These collaborations have further enriched his research and contributed to the success of his innovative projects.

Conclusion

Wei-Ying Kuo's contributions to the field of immunology through his patents and research at Academia Sinica highlight his role as a leading inventor in antibody fragment screening. His work continues to pave the way for advancements in cancer treatment and diagnostics.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…